211 related articles for article (PubMed ID: 14650932)
1. Use of benchmarking in the development of biopharmaceutical products.
Giffin M; McLeish S
Biotechnol Annu Rev; 2003; 9():279-84. PubMed ID: 14650932
[TBL] [Abstract][Full Text] [Related]
2. Development of specifications for biotechnology products--perspective from Europe.
Trouvin JH
Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
[No Abstract] [Full Text] [Related]
3. Global perspective on specifications for biotechnology products--perspective from Japan.
Hayakawa T
Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
[No Abstract] [Full Text] [Related]
4. Specifications from a biotechnology industry perspective.
Garnick RL
Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical benchmarks 2010.
Walsh G
Nat Biotechnol; 2010 Sep; 28(9):917-24. PubMed ID: 20829826
[No Abstract] [Full Text] [Related]
6. FDA perspective on specifications for biotechnology products--from IND to PLA.
Murano G
Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
[TBL] [Abstract][Full Text] [Related]
7. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
Van Buskirk GA; Asotra S; Balducci C; Basu P; DiDonato G; Dorantes A; Eickhoff WM; Ghosh T; González MA; Henry T; Howard M; Kamm J; Laurenz S; MacKenzie R; Mannion R; Noonan PK; Ocheltree T; Pai U; Poska RP; Putnam ML; Raghavan RR; Ruegger C; Sánchez E; Shah VP; Shao ZJ; Somma R; Tammara V; Thombre AG; Thompson B; Timko RJ; Upadrashta S; Vaithiyalingam S;
AAPS PharmSciTech; 2014 Jun; 15(3):665-93. PubMed ID: 24578237
[TBL] [Abstract][Full Text] [Related]
8. An Indian manufacturer's perspective for harmonization of guidelines for similar biotherapeutic products.
Babu PV
Biologicals; 2011 Sep; 39(5):300-3. PubMed ID: 21816621
[TBL] [Abstract][Full Text] [Related]
9. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
Garcia FA; Vandiver MW
PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance and quality control for biopharmaceutical products.
Geigert J
Pharm Biotechnol; 2002; 14():361-404. PubMed ID: 12189728
[No Abstract] [Full Text] [Related]
11. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
12. Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D.
Farid SS; Baron M; Stamatis C; Nie W; Coffman J
MAbs; 2020; 12(1):1754999. PubMed ID: 32449439
[TBL] [Abstract][Full Text] [Related]
13. China's perspective on similar biotherapeutic products.
Liang C; Wang J
Biologicals; 2011 Sep; 39(5):312-6. PubMed ID: 21924622
[TBL] [Abstract][Full Text] [Related]
14. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
Sahoo N; Manchikanti P
BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
[TBL] [Abstract][Full Text] [Related]
15. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies.
Demmon S; Bhargava S; Ciolek D; Halley J; Jaya N; Joubert MK; Koepf E; Smith P; Trexler-Schmidt M; Tsai P
Biologicals; 2020 Sep; 67():9-20. PubMed ID: 32665104
[TBL] [Abstract][Full Text] [Related]
16. Characterization and establishment of specifications for biopharmaceuticals.
Davis GC; Riggin RM
Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
[TBL] [Abstract][Full Text] [Related]
17. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
Thomsen MK
Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
[No Abstract] [Full Text] [Related]
18. Industry perspectives on ICH guidelines.
Rockhold FW
Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
[TBL] [Abstract][Full Text] [Related]
19. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
[TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutical benchmarks--2003.
Walsh G
Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
